Current perspective of neuroprotection and glaucoma
Kailin Tian,1,2 Shannon Shibata-Germanos,1 Milena Pahlitzsch,1 M Francesca Cordeiro1,3 1Glaucoma and Retinal Neurodegeneration Research Group, UCL Institute of Ophthalmology, London, UK; 2Eye Centre, Renmin Hospital of Wuhan University, Wuhan, People’s Republic of China; 3Western Eye Hosp...
Guardado en:
Autores principales: | Tian K, Shibata-Germanos S, Pahlitzsch M, Cordeiro MF |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a488c007d52545829d538b4a1b41dc62 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
por: Anna Galanopoulos, et al.
Publicado: (2008) -
Significance of the disc damage likelihood scale objectively measured by a non-mydriatic fundus camera in preperimetric glaucoma
por: Pahlitzsch M, et al.
Publicado: (2015) -
Current perspectives on ranibizumab
por: Dedania VS, et al.
Publicado: (2015) -
Keratoconus: current perspectives
por: Vazirani J, et al.
Publicado: (2013) -
Current primary open-angle glaucoma treatments and future directions
por: Beidoe G, et al.
Publicado: (2012)